eFFECTOR Therapeutics

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell EFTR and other ETFs, options, and stocks.

About EFTR

eFFECTOR Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development of a new class oncology drugs known as selective translation regulator inhibitors (STRIs). Its STRI product candidates target the eIF4F complex and its activating kinase, mitogen-activated protein kinase 1/2 (MNK 1/2). 

CEO
Stephen T. Worland
CEOStephen T. Worland
Employees
13
Employees13
Headquarters
Solana Beach, California
HeadquartersSolana Beach, California
Founded
2012
Founded2012
Employees
13
Employees13

EFTR Key Statistics

Market cap
23.49M
Market cap23.49M
Price-Earnings ratio
0.96
Price-Earnings ratio0.96
Dividend yield
Dividend yield
Average volume
136.56K
Average volume136.56K
High today
$0.58
High today$0.58
Low today
$0.5501
Low today$0.5501
Open price
$0.58
Open price$0.58
Volume
53.01K
Volume53.01K
52 Week high
$15.87
52 Week high$15.87
52 Week low
$0.47
52 Week low$0.47

EFTR Earnings

-$3.83
-$2.41
-$0.98
$0.44
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 7, Pre-Market
ActualExpected Nov 7, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.